Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
United Bankshares Expanding Into Florida With Planned Palm Beach Office

United Bankshares Expanding Into Florida With Planned Palm Beach Office

MT newswireMT newswire2026/10/08 13:49

09:49 AM EDT, 10/08/2026 (MT Newswires) -- United Bankshares (UBSI) said Thursday that it plans to expand into Florida with a new office in Palm Beach. The bank holding company said the new office will include a full-service banking office and will offer integrated commercial banking, private banking, wealth management, treasury management, and lending services. United Bankshares said the opening of the office is contingent on regulatory approval. Price: 45.24, Change: -0.10, Percent Change: -0.22

09:49 AM EDT, 10/08/2026 (MT Newswires) -- United Bankshares (UBSI) said Thursday that it plans to expand into Florida with a new office in Palm Beach. The bank holding company said the new office will include a full-service banking office and will offer integrated commercial banking, private banking, wealth management, treasury management, and lending services. United Bankshares said the opening of the office is contingent on regulatory approval. Price: 45.24, Change: -0.10, Percent Change: -0.22
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss